The Australian has been hit with a $155,000 fine for publishing an article referring to the criminal convictions of CFMMEU official John Setka despite repeated warnings by prosecutors about prejudicing their blackmail case against the union boss.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
Esteemed barrister Michael Wheelahan QC, who recently led Bauer Media in its successful appeal of a $4.5 million defamation award to actor Rebel Wilson, has been appointed as a Federal Court judge.
Take-Two interactive has won an injunction blocking a Grand Theft Auto gamer from distributing software that allows users to access restricted features of the popular game, a month after reaching a settlement with a gamer in a separate copyright case.
Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world’s best-selling vaccine.
Shareholders in a class action against Sirtex have secured an order forcing the life sciences company to notify them of any plan that would see its $128 million in liquid assets drop below $80 million.
Mobile garbage bin manufacturer Mastec Australia can access documents from a group of city councils and waste management firms to calculate damage it suffered from rival Trident Plastics unlawful copying of its wheelie bin design.
The funder underwriting a class action against Westpac will take a 25 percent cut of the net — not gross — recovery sum to secure a judge’s approval of a common fund order in the case.
A Melbourne computer retailer that plans to appeal a $2.8 million fine for allegedly violating Microsoft’s Windows 7 IP has won a stay of the court’s order, with a judge finding the court’s delay in publishing reasons for judgment created an “unsatisfactory state of affairs”.
A judge has rejected an application by biotech company Sirtex Medical to limit a class action to shareholders who register as group members in the next month, saying a class-closure order could dramatically cut down on the size of the class.